ProBioGen and Life Technologies Present Freedom (TM) CHO-S (TM) Platform, a Royalty-Free New cGMP Cell Line Development Kit

ProBioGen AG and Life Technologies Corporation announce the launch of the new Freedom™ CHO-S™ Kit as the result of a successful co-development.

The kit was built for developing stable high yield production cell lines in less than 4 months, and is based on Life Technologies’ CHO-S™ Cells. The Freedom™ CHO-S™ Kit platform enables end-users the cost- and time-efficient creation of stable cell lines for research and commercial purposes. The kit’s applicability and efficiency was confirmed in several studies, in which antibody titers of 1 to 3 g/L have been obtained.


The kit is sold by Life Technologies.